Governor Pence Calls for Life Sciences Expansion in Indiana

Governor Pence Calls for Life Sciences Expansion in Indiana

06.04.13 | By

At the latest Research in Your Backyard event in Indiana today, Indiana Governor Mike Pence acknowledged the many positive impacts of the clinical research conducted by biopharmaceutical companies in the Hoosier State and said he’d like to expand the partnership. 

“Indiana’s life sciences industry has tremendous potential for growth,” said Pence. “We are actively working to expand the partnership among life sciences and biopharmaceutical companies and our state’s universities and hospitals to grow the economy, to attract and retain talent and to address the critical health issues we face today.”

The “Research in Your Backyard:  Pharmaceutical Clinical Trials in Indiana” report found that biopharmaceutical companies, in collaboration with local research institutions, have conducted 3,266 clinical trials of potential new medicines since 1999, including more than 1,750 for the most debilitating chronic diseases – cancer, diabetes, heart disease, stroke, asthma and mental illnesses.

From an economic standpoint, Governor Pence’s determination to expand life sciences and biopharmaceutical research collaborations in the state is understandable:  According to a report by BioCrossroads, a catalyst organization for life sciences development in Indiana, pharmaceuticals accounted for nearly $5 billion of the $7.4 billion in life science product exports from the state in 2009.

And life science exports overall nearly tripled in Indiana from $2.5 billion to $7.4 billion from 2002 to 2009, ranking Indiana as third-highest among the states, behind only California and Texas, according to BioCrossroads.

PhRMA’s Chip Davis also stressed the benefits of clinical trials for local patients. Over 250 of the chronic disease medicine clinical trials in Indiana are still active and seeking participants and Davis said trials of new treatments could be a good therapeutic option for some patients still seeking other treatment options.

Today’s roll-out of an Indiana clinical trial report marks the 20th “Research in Your Backyard” report released since October, 2011.  

Read the full "Research in Your Backyard: Pharmaceutical Clinical Trials in Indiana" report here.


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context